Stay updated with breaking news from Nasdaq Grph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) has been assigned an average recommendation of “Hold” from the seven analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have issued a buy recommendation on the company. The […]
Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) saw a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 2,580,000 shares, a decline of 36.0% from the March 31st total of 4,030,000 shares. Approximately 10.7% of the company’s shares are sold short. Based on an average […]
Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 4,030,000 shares, a growth of 33.0% from the March 15th total of 3,030,000 shares. Based on an average daily volume of 296,200 shares, the […]
Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) insider Phil Gutry purchased 5,000 shares of the stock in a transaction that occurred on Monday, April 11th. The shares were purchased at an average cost of $4.01 per share, with a total value of $20,050.00. Following the completion of the acquisition, the insider now owns 299,941 shares […]
Graphite Bio, Inc. (NASDAQ:GRPH – Get Rating) major shareholder Biocapital L.P. Samsara acquired 74,464 shares of the firm’s stock in a transaction that occurred on Monday, April 11th. The stock was acquired at an average price of $4.07 per share, with a total value of $303,068.48. Following the completion of the acquisition, the insider now […]